# Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma

Source: https://onco.cc/trials/nct07786766/  
OnCo record `nct07786766` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of pemigatinib in gallbladder cancer and other biliary tract cancers, run by Haitao Zhao, MD, now recruiting.

## Summary

Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma is a phase 2 interventional study registered as NCT07786766 by Haitao Zhao, MD, with a registry enrolment figure of 154 participants, started 2026-08-20 and due to reach its primary completion in 2027-12-31. Interventions recorded: Pemigatinb, PD-1 inhibitors, Chemotherapy. Conditions listed: Biliary Tract Cancer (BTC). Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07786766
- Phase: 2
- Setting: An Open-Label, Phase II Clinical Study Evaluating the Efficacy and Safety of Pemigatinib in Combination With a PD-1 Inhibitor, With or Without Chemotherapy, in Patients With Unresectable or Metastatic Cholangiocarcinoma Harboring FGFR2 Fusions or Rearrangements
- Sponsor: Haitao Zhao, MD
- Enrolled: 154

## Sources

- ClinicalTrials.gov NCT07786766: https://clinicaltrials.gov/study/NCT07786766

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Pemigatinib](https://onco.cc/drugs/pemigatinib/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07786766.json